The under eye area
More people come to this treatment for the under eye area than for anything else. It is also the area where the anatomy, the swelling and the absence of a reversal agent combine least helpfully.
The skin beneath the eye is the thinnest on the body, it overlies a compartment that swells readily, its lymphatic drainage is limited, and the regional vascular anatomy includes connections that make an injection into a vessel here a serious event. Prolonged swelling and palpable or visible lumps are reported in this area more than elsewhere, and because polynucleotides have no reversal agent, the response to an unwanted result is waiting.
None of that means the area cannot be treated. It means that experience specific to this area, a clear account of what happens if swelling persists, and a realistic assessment of whether your particular under eye concern is a skin quality problem at all, matter more here than anywhere else.
3.3.1What makes this area different
Three things, and they compound.
The skin is extremely thin. Anything placed beneath it is closer to the surface and more likely to be visible as a contour irregularity. Swelling that would be unnoticed in a cheek is conspicuous here.
Drainage is limited. The tissue beneath the lower eyelid holds fluid readily and clears it slowly. This is the same reason people wake with puffiness here and not elsewhere. An injection that adds fluid and water binding material to that compartment is working against the local drainage.
The vascular anatomy is unforgiving. Vessels in the periorbital region have connections towards the orbit and its contents. Inadvertent intravascular injection of any material in this region is recognised across aesthetic medicine as a serious event, and it is the reason practitioners treating here need to understand the anatomy properly rather than approximately.
3.3.2Is your concern actually a skin quality problem
This is the question that gets skipped, and skipping it is the most common route to disappointment. Under eye appearance is produced by several distinct things, and a treatment aimed at skin quality addresses only one of them.
- Shadowing from bone structure. A hollow beneath the eye casts a shadow. That is a structural feature and no amount of hydrating the skin over it will change the shadow.
- Fat compartment change. Herniation or descent of the fat pads produces bags and a defined boundary. This is structural and is a surgical or volumising question, not a skin quality one.
- Pigmentation. Constitutional or post inflammatory pigmentation in the skin itself. A different problem with different treatments, and one where the underlying cause matters.
- Vascular visibility. Vessels showing through thin skin. Making the skin better hydrated may reduce translucency slightly and will not remove the vessels.
- Skin quality and fine crepiness. The one thing in this list that a treatment of this kind is aimed at.
- Fluid retention. Which fluctuates, is affected by sleep, salt, alcohol and allergy, and can make any assessment unreliable if it is not accounted for.
A practitioner who examines the area, tells you which of these is contributing in your case, and says candidly which ones this treatment will not touch, is doing the job properly. A practitioner who proposes the treatment without that analysis is selling a product rather than assessing a face.
| Contributing factor | What it is | Addressed by a skin quality injectable |
|---|---|---|
| Bone structure and hollowing | A shadow cast by contour | No |
| Fat compartment change | Bags, herniation, descent | No |
| Pigmentation | Constitutional or post inflammatory | No |
| Vascular visibility | Vessels seen through thin skin | Marginally at most |
| Skin texture and fine crepiness | Dermal quality | This is the target |
| Fluid retention | Fluctuating, affected by sleep, salt, alcohol, allergy | No, and it makes assessment unreliable |
A framework written by this publication to organise a decision. It is not a measurement, it is not drawn from any study, and no figure in it should be quoted as a finding.
3.3.3Prolonged swelling, specifically
The complication most associated with this area is swelling that persists beyond the expected few days, sometimes for weeks. It is reported across injectable treatments in this region and is not unique to polynucleotides. It is not usually dangerous. It is distressing, it is visible, and with a product that cannot be dissolved, the management is time, reassurance, and treating any contributing factor.
Before agreeing to treatment here, ask two specific questions. What is your experience of prolonged swelling in this area, and what do you do about it? A practitioner who has treated this area extensively will have seen it and will have a considered answer. One who says it does not happen is either inexperienced in the area or is not telling you.
3.3.4Lumps and irregularity
Palpable or visible lumps after injection in this area are reported. They may be product related, tissue reaction, or a consequence of placement. With hyaluronic acid there is a route to address them. Here, there is not.
That single asymmetry is the reason this article exists. The same complication in the same place has a very different trajectory depending on which material was used, and that difference belongs in the consent conversation rather than in a footnote.
3.3.5The serious event, and what to know about it
Vascular occlusion, in which injected material enters or compresses a blood vessel and interrupts blood supply, is the serious complication of facial injectables generally. It is uncommon. It is a medical emergency. In the periorbital region the potential consequences include effects on vision.
You do not need to be able to manage this. You need to know three things. That it exists and that severe pain, disproportionate pain, blanching or mottling of the skin, or any visual change during or after treatment is urgent. That your practitioner should have a written protocol and the means to act on it. And that if you cannot reach them, urgent NHS care is the correct route, through 111 or, for visual symptoms or severe pain, an emergency department.
3.3.6What to establish before agreeing
- Which components of my under eye appearance will this address, and which will it not?
- How many times have you treated this specific area with this specific product?
- Does the manufacturer's intended use cover the periorbital area?
- What is your experience of prolonged swelling here, and what do you do about it?
- What is your protocol for a vascular event, and how do I reach you urgently?
- Given there is no reversal agent, what are my options if I am unhappy with the result?
If those six questions produce good answers, you are in reasonable hands. If they produce reassurance without specifics, the area is too unforgiving to proceed on reassurance.
Questions
Will this get rid of my dark circles?
It depends entirely on what is causing them, and in most people the main contributors are structural or pigmentary rather than related to skin quality. A practitioner should examine the area and tell you which components apply to you and which this treatment will not touch.
Why does swelling here last longer than elsewhere?
The tissue beneath the lower eyelid holds fluid readily and drains it slowly, and the skin over it is thin enough that any swelling is conspicuous. Adding a water binding material to that compartment works against the local drainage for a period.
What happens if I get a lump?
With polynucleotides there is no reversal agent, so management is time and symptomatic treatment rather than dissolving. This is the single most important difference from hyaluronic acid in this area and it belongs in your consent conversation.
What is the emergency I should know about?
Vascular occlusion, where injected material interrupts blood supply. It is uncommon and it is urgent. Severe or disproportionate pain, blanching or mottling of the skin, or any change in vision during or after treatment needs immediate attention. If you cannot reach your practitioner, use NHS urgent care, and for visual symptoms an emergency department.
Is anyone qualified enough to treat here?
Plenty of practitioners are. What you want is experience in this specific area rather than in injectables generally, a clear account of what they do when swelling persists, and a written emergency protocol they can describe to you. Those three answers separate people quickly.
- NHS, Dermal fillers
- NHS, Plastic surgery
- NHS 111 online
- British Association of Dermatologists
- Joint Council for Cosmetic Practitioners
Links to regulators, professional bodies, legislation and research indexes. They are cited because they are public and checkable, not as endorsement of this publication. No source listed here has any commercial relationship with us.
Revisions to this document
This reference is revised when the evidence changes. Subscribe and you will be told what was revised, what the verdict was before, and what it is now.
One email when this document is revised, with what changed and why. Any sponsor line is labelled as such and can never influence an evidence verdict. Rates are published on the newsletter page. We do not sell, share or rent the list. Unsubscribe from any email.